Additionally, MDSCs in HR+ BC can secrete cytokines, IL-6, and chemokine ligands (CCLs) like CCL2, suppressing T-cell function and recruiting more immune-suppressive cells to the TME, reinforcing the cold tumor phenotype. The gene discussed is CCL2; the disease is breast cancer.